Taken together, our data suggest that loss-of-function Fbw7 mutations in cancer cells could result in the stabilization of pre-existing nuclear SREBP1 molecules, enhanced expression of SREBP target genes and the accumulation of intracellular lipids, thereby triggering the feedback mechanism controlling the activation of SREBP2. The gene discussed is FBXW7; the disease is cancer.